Predicting Toxicity: Biomarkers and the Value of the Patient's Opinion
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
233-240
Author(s):
MJ Garcia de Yebenes, E Loza and L Carmona
Pro-Oxidative Action of Polyphenols as Action Mechanism for their Pro-Apoptotic Activity
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
1363-1375
Author(s):
Raffaella Marina Lecci, Antonio Logrieco and Antonella Leone
Management of Inflammatory Bowel Disease Patients with a Cancer History
Journal:
Current Drug Targets
Volume:
15
Page:
1042-1048
Author(s):
Laurent Beaugerie
Nanoparticles in Melanoma
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3701-3716
Author(s):
M.A. Berciano-Guerrero, A. Montesa-Pino, G. Castaneda-Penalvo, L. Munoz-Fernandez and J. Rodriguez-Flores
Psoriasis and Vascular Risk : An Update
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6114-6125
Author(s):
Niki Katsiki, Panagiotis Anagnostis, Vasilios G. Athyros, Asterios Karagiannis and Dimitri P. Mikhailidis
Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5594-5618
Author(s):
Pilar Roca, Jorge Sastre-Serra, Mercedes Nadal-Serrano, Daniel Gabriel Pons, Ma del Mar Blanquer-Rossello and Jordi Oliver
Is Tretinoin Still a Key Agent for Photoaging Management?
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
14
Page:
629-641
Author(s):
Andreia Ascenso, Helena Ribeiro, Helena C. Marques, Helena Oliveira, Conceicao Santos and Sandra Simões
Minireview: Peptide Analogs and Short Sequence Oligopeptides as Modulators of Skin Pigmentation
Journal:
Current Topics in Medicinal Chemistry
Volume:
14
Page:
1418-1424
Author(s):
Anan Abu Ubeid and Basil M. Hantash
The Long and Winding Road to Cancer Treatment: The Trail System
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2819-2833
Author(s):
Carmen Palacios, Rosario Yerbes, Tania Sanchez-Perez, Rosa Martin-Perez, Ana Cano-Gonzalez and Abelardo Lopez-Rivas
Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer
Journal:
Current Clinical Pharmacology
Volume:
9
Page:
139-147
Author(s):
Helgi H. Helgason, Stijn L.W. Koolen, Erik van Werkhoven, Mirte M. Malingre, C. Marielle F. Kruijtzer, Alwin D.R. Huitema, Margaret E. Schot, Wim M. Smit, Jos H. Beijnen and Jan H.M. Schellens